Find activities

489 results

  • Canakinumab for treating periodic fever syndromes: TRAPS, HIDS/MKD and FMF (ages 2 and older)

    NHS England has launched a 30 day consultation on the use of canakinumab for treating periodic fever syndromes: tumour necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome/mevalonate kinase deficiency (HIDS/MKD) and familial Mediterranean fever (FMF). Related documents Policy Proposition Engagement Report Evidence Review Impact Assessment CPAG Summary Report More
    Closed 1 September 2019

  • Equality and Diversity in NHS Communications

    As part of its on-going commitment to tackle equality and diversity issues, the London NHS Communications Network is inviting you to complete this survey. This survey aims to: Gather valuable insights from the NHS communications community that will inform what actions could be taken to address racial inequality and further promote equality in the NHS communications network. Gather a picture of who is currently working in our industry and what their roles entail. Reflect... More
    Closed 30 August 2019

  • Proposed changes to out of hours dental services in the West Midlands

    This is a questionnaire in support of the c onsultation on proposed changes to ‘out of hours dental services in the West Midlands’. For full details of what is proposed please see the following: Needs Assessment (current services and future needs) Consultation Document (why we are consulting) Frequently asked questions Please note that these proposals do not affect existing in hours dental services provided through high street... More
    Closed 30 August 2019

  • Digital-first Primary Care: Policy consultation on patient registration, funding and contracting rules

    All around us, a new generation of technology is changing our lives. Each year more of us choose online routes to book GP appointments, order repeat prescriptions or view personal health records. Digital innovations have the potential to support and empower patients, helping people to remain healthy and independent for longer. Used well, new technologies can also help to alleviate workload challenges in practices. The NHS Long Term Plan commits that every patient will... More
    Closed 23 August 2019

  • Ablative surgery, moulage technique brachytherapy and surgical reconstruction for head and neck soft tissue sarcoma in children and young people

    NHS England has launched a 30 day consultation on a policy proposition for ablative surgery, moulage technique brachytherapy and surgical reconstruction for head and neck soft tissue sarcoma in children and young people. Related documents Policy proposition Evidence review Evidence report Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report More
    Closed 22 August 2019

  • Dexrazoxane for preventing cardiotoxicity in children and young people (< 25 years) receiving high-dose anthracyclines or related drugs for the treatment of cancer

    NHS England has launched a 30 day consultation on a policy proposition for dexrazoxane for preventing cardiotoxicity in children and young people (< 25 years) receiving high-dose anthracyclines or related drugs for the treatment of cancer. Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report Clinical panel report CPAG summary report More
    Closed 22 August 2019

  • Idebenone for treating visual impairment in adults and young people with Leber's hereditary optic neuropathy

    NHS England has launched a 30 day consultation on idebenone for treating visual impairment in adults and young people with Leber's hereditary optic neuropathy. Related documents Policy proposition Stakeholder engagement report Evidence review CPAG summary report Impact assessment report Clinical evidence evaluation More
    Closed 22 August 2019

  • Temozolomide as adjuvant treatment newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (adults)

    Temozolomide is an oral medicine that works by stopping cancer cells from making deoxyribonucleic acid (DNA), thereby preventing cell growth. It is proposed to be an additional adjuvant treatment option for people with newly-diagnosed anaplastic astrocytoma who have already been treated with surgery and radiotherapy. NHS England has launched a 30 day consultation on a policy proposition on commissioning the use of temozolomide as adjuvant treatment for adults with newly diagnosed... More
    Closed 10 August 2019

  • Survey on NHS Domiciliary Dental Services in Derbyshire and Nottinghamshire

    The contracts to provide domiciliary dental services in the Derbyshire and Nottinghamshire are due to expire at the end of March 2020. NHS England and NHS Improvement - Midlands is planning to commission new contracts to continue provision of this service and would like to ask patients and other service users who access this service to give their feedback on the current services, to ensure that the domiciliary dental service provision will meet the needs of the local population it serves. ... More
    Closed 6 August 2019

  • Children's Cancer Services

    NHS England has launched a 60-day consultation to seek views on proposed changes to children's cancer services. These are used by children aged between 0 and 16. In some cases, and with the agreement of Teenage and Young Adult's Cancer Services, they may also treat teenagers up to the age of 18. The aim of the service specifications is to improve the outcomes and experience of children and young people with cancer. This consultation guide sets out: How care is currently... More
    Closed 4 August 2019

  • Teenager and Young Adults Cancer Services

    NHS England has launched a 60-day consultation to seek views on proposed changes to teenager and young adult's cancer services. These are used by teenagers and young people aged between 16 up to the day before their 25th birthday. In some cases, and with the agreement of Children's Cancer Services, they may also treat teenagers from the age of 13. The aim of the service specifications is to improve the outcomes and experience of teenagers and young adults with cancer. This... More
    Closed 4 August 2019

  • Telotristat for treating carcinoid syndrome diarrhoea (Adults)

    NHS England has launched a 2 month consultation on a policy proposition for telotristat for treating carcinoid syndrome diarrhoea (Adults). Related documents Policy proposition Evidence review Evidence report Impact assessment report Stakeholder engagement report CPAG summary report More
    Closed 30 July 2019

  • Consultation on proposed changes to ‘The transfer and remission of adult prisoners under the Mental Health Act 1983 good practice guidance 2019’ and introduction of ‘The transfer and remission of immigration removal centre detainees under the Mental Health Act 1983 good practice guidance 2019’

    Publishing approval reference: 000647 NHS England and NHS Improvement have launched a national consultation on guidance relating to individuals held within prisons and immigration removal centres (IRCs) who have been detained under the Mental Health Act for assessment and treatment within mental health in-patient services. The consultation focuses on two proposed documents, which set out information and guidance on the transfer of these individuals to mental health in-patient... More
    Closed 19 July 2019

  • Addition of Rituximab to firstline standard chemotherapy for CD20 positive B-cell precursor Acute Lymphoblastic Leukaemia (adults)

    NHS England has launched a 6 week consultation on a policy proposition for addition of Rituximab to firstline standard chemotherapy for CD20 positive B-cell precursor Acute Lymphoblastic Leukaemia (adults). Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report Clinical panel report More
    Closed 12 July 2019

  • Survey on GP services at Mevagissey Surgery

    As joint commissioners, NHS England and NHS Improvement and NHS Kernow Clinical Commissioning Group are looking at alternative options for patients of Mevagissey Surgery. We are asking for valuable feedback from patients to understand how this could affect you and what impacts there may be in terms of accessibility, travel and range of services provided. Please answer as many questions as you can, as the more information we can collect, the better our... More
    Closed 5 June 2019

  • Help us shape the NHS England Midlands and East regional website

    NHS Midlands and East of England would like to know more about how you use our regional website: www.england.nhs.uk/mids-east/ . We will use the information you provide to make sure our two regional websites meet the needs of all our visitors. This short survey will take no longer than five minutes to complete. You can save and exit the questionnaire at any time. You can be assured that NHS England will not use the information you provide for any other purpose than user... More
    Closed 31 May 2019

  • Emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors (all ages)

    NHS England has launched a 30 day consultation on Emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors (all ages). Haemophilia A is a rare condition that affects the blood's ability to clot. It is usually inherited and usually occurs in males. Emicizumab is a drug used to prevent bleeding or reduce the number of bleeds in people with haemophilia A. Emicizumab works by mimicking the action of factor VIII. Emicizumab binds to factor X... More
    Closed 12 May 2019

  • Implementing the NHS Long Term Plan - Proposals for possible changes to legislation

    We are inviting patients, NHS staff, partner organisations and interested members of the public to give us your views on potential proposals for changing current primary legislation relating to the NHS. It’s possible to implement the NHS Long Term Plan without primary legislation. But legislative change could make implementation easier and faster. Local NHS bodies need to be free to work together with partners, including local authorities, to plan and provide care around... More
    Closed 25 April 2019

  • Clinical Reference Group Stakeholder Registration

    When commissioning specialised services, ensuring all stakeholders have the opportunity to be involved and contribute their views is vital. Our Clinical Reference Group stakeholder lists enable this to happen. Registration is open for all, including patients, carers, voluntary sector partners, clinical staff and provider organisations working in specialised services. Registered stakeholders are kept informed of relevant updates relating to their areas of interest. They are also invited... More
    Opened 3 April 2019

  • Lung volume reduction, policy proposition

    NHS England has completed a 30 day consultation on a policy proposition on lung volume reduction. This consultation ran from 25 February to 27 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Stakeholder engagement report CPAG summary report Clinical panel report 1 Clinical panel report 2 Impact assessment report Evidence report Evidence review: LVR... More
    Closed 27 March 2019

  • Percutaneous mitral valve leaflet repair for mitral regurgitation

    NHS England has completed a 30 day consultation on a policy proposition on percutaneous mitral valve leaflet repair for mitral regurgitation. This consultation ran from 25 February to 27 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report ... More
    Closed 27 March 2019

  • Bictegravir / emtricitabine / tenofovir alafenamide for HIV

    NHS England has completed a 30 day consultation on a policy proposition for HIV-1; bictegravir / emtricitabine / tenofovir alafenamide (B/F/TAF). This consultation ran from 25 February to 27 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report Clinical panel report More
    Closed 27 March 2019

  • Percutaenous patent foramen ovale closure for prevention of recurrent cerebral embolic stroke

    NHS England has completed a 30 day consultation on a policy proposition on percutaenous patent foramen ovale closure for prevention of recurrent cerebral embolic stroke. This consultation ran from 25 February to 27 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical... More
    Closed 27 March 2019

  • Cholic acid in combination with chenodeoxyholic acid for inborn errors for bile synthesis

    NHS England has completed a 30 day consultation on a policy proposition on cholic acid and chenodeoxycholic acid for treating inborn errors of bile acid synthesis. This consultation ran from 22 February to 24 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Evidence review 1 Evidence review 2 Evidence review 3 Impact assessment report Stakeholder engagement... More
    Closed 24 March 2019

  • Bone marrow transplant for primary immunodeficiencies

    NHS England has completed a 30 day consultation on a policy proposition on Bone Marrow Transplant for Primary Immunodeficiencies (all ages). This consultation ran from 22 February to 24 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Evidence review 1 Evidence review 2 Impact assessment report Stakeholder engagement report CPAG summary report Clinical... More
    Closed 24 March 2019

  • GDP Facilities Scoping Exercise

    As a current provider of NHS dental services, NHS England is asking you to complete this survey to understand the type of facilities you have within your practice. This information will be added to the practice information we hold within the Directory of Services (DoS), which is the database used by NHS111/Dental Helpline. The results of the survey will also be shared with the Managed Clinical Networks (MCNs) to help understand what facilities there are to support patients with... More
    Closed 21 March 2019

  • Penile Prosthesis Surgery (for end stage erectile dysfunction)

    NHS England has launched a 60 day consultation on a draft service specification for penile prosthesis surgery for end stage erectile dysfunction. Related documents Consultation Guide Draft Service Specification Stakeholder Engagement Report Impact Assessment More
    Closed 19 March 2019

  • Hand and Upper Limb Transplant Service Specification

    NHS England has launched a 30 day consultation on a draft specification for hand and upper limb transplant services. Related documents Service Specification CPAG summary report Engagement report Impact assessment report More
    Closed 10 March 2019

  • Expressions of interest in the NHS Assembly

    We invite expressions of interest to become a member of the NHS assembly. Following the recent publication of the NHS Long Term Plan, NHS England and NHS Improvement are inviting expressions of interest to become a member of the new NHS Assembly. Building on the collaborative approach to developing the NHS Long Term Plan, the NHS Assembly is a new national forum that will regularly bring together a range of stakeholders from across the health and care system to advise the boards of NHS... More
    Closed 6 March 2019

  • Stereotactic ablative radiotherapy for small cell lung cancer and stage I-III non small cell primary lung cancer (excluding early stage non small cell lung cancer unsuitable for surgery) (all ages)

    NHS England has launched a six week consultation on a draft policy proposition for Stereotactic ablative radiotherapy for small cell lung cancer and stage I-III non small cell primary lung cancer. Related documents Policy Proposition Impact Assessment Stakeholder Engagement Report CPAG Summary Report: SABR for Small Cell Lung Cancer CPAG Summary Report: SABR for Non-Small Cell Lung Cancer Clinical Panel Report Evidence Review: SABR for Small... More
    Closed 1 March 2019
489 results. Page 8 of 17